CD4 and neoplasm: Cancer vaccines are designed to deliver tumour antigens or their genes to APCs, which, when processed, activate anti-cancer cytotoxic T-cell and helper T-cell (CD4+ cells) responses and produce immune memory to provide long term anti-cancer action [92,93].